By Ransdell Pierson NEW YORK (Reuters) - Johnson & Johnson may soon cause frown lines at Allergan Inc, maker of Botox. J&J expects to seek U.S. approval next year for an anti-wrinkle drug that could break Botox's near monopoly, an 85 percent m...
Source: http://health.yahoo.net/news/s/nm/analysis-j-j-s-answer-to-botox-may-escalate-war-on-wrinkles
found it for you found it I found it found here
No comments:
Post a Comment
Note: only a member of this blog may post a comment.